Does this key event move Imara Inc.’s stock (Nasdaq: IMRA) in the morning session?
Imara Inc. (Nasdaq: IMRA) is a biotech, clinical-stage firm dedicated to making and selling therapy to treat patients with rare genetic disorders of hemoglobin (Hb). Imara Inc. (Nasdaq: IMRA), shares dropped -32.57% to $16.00 in the early morning session after the company announced findings from its phase 2a IMR-687 clinical trial in adult sickle cell disease […]
Top 3 Casino Stocks to Watch For in 2021
The gambling industry is all about risk and where there is a risk, there is a high-return. Casino stocks are gaining momentum after a soggy 2020. CNBC’s Jim Cramer anticipates the Casino stocks to jump with traveling coming to life. Moreover, the trade tension between the U.S. and China seems to cool down, which can […]
Skyworks Solutions [SWKS] Unchanged to Overweight at KeyBanc
KeyBanc maintained its Skyworks Solutions [SWKS] rating to the equivalent of Overweight but changed the price target to $180 from $170, in a research note dated 2021-01-06. That figure represents around a 15.16% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with The Benchmark Company’s analysts reiterating the […]
R1 RCM [RCM] gets its Overweight rating reiterated by KeyBanc
KeyBanc maintained its R1 RCM [RCM] rating to the equivalent of Overweight but changed the price target to $26 from $24, in a research note dated 2021-01-06. That figure represents around a 12.85% premium from where the company’s shares closed on Tuesday. Some new analysts also started their coverage, with RBC Capital Mkts’s analysts assigning […]
Synaptics [SYNA] Unchanged to Overweight at KeyBanc
KeyBanc maintained its Synaptics [SYNA] rating to the equivalent of Overweight but changed the price target to $120 from $100, in a research note dated 2021-01-06. That figure represents around a 21.83% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with KeyBanc Capital Markets’s analysts upgrading the shares […]
Teradyne [TER] gets its Overweight rating reiterated by KeyBanc
KeyBanc maintained its Teradyne [TER] rating to the equivalent of Overweight but changed the price target to $138 from $115, in a research note dated 2021-01-06. That figure represents around a 13.59% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with Goldman’s analysts upgrading the shares from “a […]
Teleflex [TFX] Stock Gets Reiterated At Needham. It’s Still Buy
Needham maintained its Teleflex [TFX] rating to the equivalent of Buy but changed the price target to $445.0 from $406, in a research note dated 2021-01-06. That figure represents around a 11.13% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with Needham’s analysts reiterating the shares to “a […]
Wells Fargo upgrades CenterPoint Energy [CNP] to Overweight and price target to $24
Wells Fargo took its CenterPoint Energy [CNP] rating to the equivalent of Overweight from Equal Weight, and the price target to $24 from $25, in a research note dated 2021-01-06. That figure represents around a 11.32% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with BofA Securities’s analysts […]
Citigroup lifts JB Hunt Transport Services [JBHT] rating to Buy
Citigroup took its JB Hunt Transport Services [JBHT] rating to the equivalent of Buy from Neutral, in a research note dated 2021-01-06. Some new analysts also started their coverage, with Wells Fargo’s analysts assigning the shares to “an Overweight” rating in a research note to investors issued in late September. Meanwhile, Evercore ISI had launched […]
Cintas [CTAS] Upgraded to Equal-Weight at Morgan Stanley
Morgan Stanley took its Cintas [CTAS] rating to the equivalent of Equal-Weight from Underweight, and the price target to $324 from $261, in a research note dated 2021-01-06. That figure represents around a -7.13% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with BofA/Merrill’s analysts downgrading the shares […]
